HoloSIM: Mixed Reality Medical Student Training in Complex Crisis Scenarios (HoloSIM)

September 10, 2022 updated by: Julian Wiegelmann, Sunnybrook Health Sciences Centre

HoloSIM: The Way Forward in Complex Crisis Training

In this study, Investigators will test a mixed reality software platform to improve and help for teaching and assessment of anesthesia crisis management among medical students.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Ontario
      • Toronto, Ontario, Canada, M4E 3M4

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • ADULT
  • OLDER_ADULT
  • CHILD

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • University of Toronto Medical student volunteers

Exclusion Criteria:

  • Unwilling to enter the study
  • Deficit of vision or hearing incompatible with Microsoft Hololens 2 use

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Training by Mixed Reality Simulation
Medical students will train via a mixed reality simulated crisis scenario using the HoloSIM software on the Microsoft Hololens 2
ACTIVE_COMPARATOR: Training by Mannequin Based Simulation
Medical students will train a via traditional mannequin based medical crisis scenario

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Anaphylaxis Checklist of Core Decision Making Steps
Time Frame: one week post exposure
Expert consensus based checklists of critical scenario actions on a mannequin based crisis scenario. Student scenario performance graded from 0 to 45, with higher scores representing a better performance.
one week post exposure

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Usability Score
Time Frame: Immediately after exposure
Likert scale (5 point) based assessment of software usability. Higher scores on a scale of 1 to 5 represent a better software system usability.
Immediately after exposure
Learning Satisfaction Score
Time Frame: Immediately after exposure
Likert scale (5 point) based assessment of learning satisfaction. Higher scores on a scale of 1 to 5 represent a greater degree of learning satisfaction.
Immediately after exposure
Time required to complete critical crisis related tasks
Time Frame: one week post exposure
Measured time until critical scenario management events occur
one week post exposure

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

August 24, 2021

Primary Completion (ANTICIPATED)

April 1, 2023

Study Completion (ANTICIPATED)

April 1, 2023

Study Registration Dates

First Submitted

September 2, 2020

First Submitted That Met QC Criteria

October 15, 2020

First Posted (ACTUAL)

October 19, 2020

Study Record Updates

Last Update Posted (ACTUAL)

September 13, 2022

Last Update Submitted That Met QC Criteria

September 10, 2022

Last Verified

September 1, 2022

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • SUN-2124

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Educational Problems

Clinical Trials on HoloSIM Software via Hololens 2

3
Subscribe